<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Rooney AG</submitter><funding>Medical Research Foundation</funding><funding>Brain Tumour Charity</funding><funding>Medical Research Council</funding><funding>MRF_</funding><funding>The Brain Tumour Charity</funding><pagination>249-260</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10180387</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>10(3)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>There are no effective treatments for brain tumor-related fatigue. We studied the feasibility of two novel lifestyle coaching interventions in fatigued brain tumor patients.&lt;h4>Methods&lt;/h4>This phase I/feasibility multi-center RCT recruited patients with a clinically stable primary brain tumor and significant fatigue (mean Brief Fatigue Inventory [BFI] score ≥ 4/10). Participants were randomized in a 1-1-1 allocation ratio to: Control (usual care); Health Coaching ("HC", an eight-week program targeting lifestyle behaviors); or HC plus Activation Coaching ("HC + AC", further targeting self-efficacy). The primary outcome was feasibility of recruitment and retention. Secondary outcomes were intervention acceptability, which was evaluated via qualitative interview, and safet</pubmed_abstract><journal>Neuro-oncology practice</journal><pubmed_title>Lifestyle coaching is feasible in fatigued brain tumor patients: A phase I/feasibility, multi-center, mixed-methods randomized controlled trial.</pubmed_title><pmcid>PMC10180387</pmcid><funding_grant_id>GN000436</funding_grant_id><funding_grant_id>MR/J000914/1</funding_grant_id><funding_grant_id>C0396</funding_grant_id><funding_grant_id>GN-000436</funding_grant_id><pubmed_authors>Grant R</pubmed_authors><pubmed_authors>Hill R</pubmed_authors><pubmed_authors>Carruthers J</pubmed_authors><pubmed_authors>Day J</pubmed_authors><pubmed_authors>Rooney AG</pubmed_authors><pubmed_authors>Clark A</pubmed_authors><pubmed_authors>Bulbeck H</pubmed_authors><pubmed_authors>Mackinnon M</pubmed_authors><pubmed_authors>Wells M</pubmed_authors><pubmed_authors>Walker A</pubmed_authors><pubmed_authors>Gillespie D</pubmed_authors><pubmed_authors>Chalmers AJ</pubmed_authors><pubmed_authors>Hewins W</pubmed_authors><pubmed_authors>Dunlop J</pubmed_authors><pubmed_authors>Emerson J</pubmed_authors><pubmed_authors>Withington L</pubmed_authors><pubmed_authors>Hewitt C</pubmed_authors><pubmed_authors>Hopcroft LEM</pubmed_authors><pubmed_authors>Cochrane C</pubmed_authors><pubmed_authors>Dyson A</pubmed_authors><pubmed_authors>McBain C</pubmed_authors><pubmed_authors>Robson S</pubmed_authors><pubmed_authors>Torrens C</pubmed_authors><pubmed_authors>Anderson G</pubmed_authors><pubmed_authors>Welsh M</pubmed_authors><pubmed_authors>Molinari E</pubmed_authors></additional><is_claimable>false</is_claimable><name>Lifestyle coaching is feasible in fatigued brain tumor patients: A phase I/feasibility, multi-center, mixed-methods randomized controlled trial.</name><description>&lt;h4>Background&lt;/h4>There are no effective treatments for brain tumor-related fatigue. We studied the feasibility of two novel lifestyle coaching interventions in fatigued brain tumor patients.&lt;h4>Methods&lt;/h4>This phase I/feasibility multi-center RCT recruited patients with a clinically stable primary brain tumor and significant fatigue (mean Brief Fatigue Inventory [BFI] score ≥ 4/10). Participants were randomized in a 1-1-1 allocation ratio to: Control (usual care); Health Coaching ("HC", an eight-week program targeting lifestyle behaviors); or HC plus Activation Coaching ("HC + AC", further targeting self-efficacy). The primary outcome was feasibility of recruitment and retention. Secondary outcomes were intervention acceptability, which was evaluated via qualitative interview, and safet</description><dates><release>2023-01-01T00:00:00Z</release><publication>2023 Jun</publication><modification>2026-07-14T17:01:07.48Z</modification><creation>2025-04-05T09:11:35.449Z</creation></dates><accession>S-EPMC10180387</accession><cross_references><pubmed>37188163</pubmed><doi>10.1093/nop/npac086</doi></cross_references></HashMap>